Woodline Partners LP Regeneron Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 99,417 shares of REGN stock, worth $77.8 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

99,417

Previous 181,897 45.34%

Holding current value

$77.8 Million

Previous $191 Million 45.33%

% of portfolio

0.95%

Previous 1.92%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $84.5 Million - $99.1 Million	-82,480 Reduced 45.34%	99,417 $105 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $9.98 Million - $12.1 Million	11,295 Added 6.62%	181,897 $191 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $462,177 - $508,595	512 Added 0.3%	170,602 $164 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $26 Million - $29.6 Million	33,518 Added 24.54%	170,090 $149 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $61.6 Million - $75.1 Million	88,910 Added 186.54%	136,572 $112 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $74.7 Million - $88.6 Million	-106,659 Reduced 69.12%	47,662 $34.2 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $3.52 Million - $4.28 Million	-5,172 Reduced 3.24%	154,321 $127 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $19.7 Million - $21.4 Million	-27,864 Reduced 14.87%	159,493 $115 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $77.2 Million - $97.5 Million	134,565 Added 254.9%	187,357 $129 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $28.9 Million - $38.9 Million	-52,702 Reduced 49.96%	52,792 $31.2 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $9.07 Million - $10.6 Million	15,248 Added 16.9%	105,494 $73.7 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $7.83 Million - $9.66 Million	14,400 Added 18.99%	90,246 $57 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $1.16 Million - $1.37 Million	-2,013 Reduced 2.59%	75,846 $45.9 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $51.1 Million - $60.3 Million	-108,040 Reduced 58.12%	77,859 $43.5 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $74 Million - $90.8 Million	165,695 Added 820.11%	185,899 $88 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $9.66 Million - $12.3 Million	20,204 New	20,204 $9.76 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $16.7 Million - $20.2 Million	-30,722 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $1.6 Million - $2.09 Million	3,245 Added 11.81%	30,722 $19.2 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $9.24 Million - $13.6 Million	27,477 New	27,477 $13.4 Million

Others Institutions Holding REGN

# of Institutions

1,524

Shares Held

84M

Call Options Held

1.14M

Put Options Held

1.48M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Regeneron Pharmaceuticals, Inc. Transaction History